Asymptomatic Carriage Rate, Multidrug Resistance Level, and Associated Risk Factors of Enterococcus in Clinical Samples among HIV-Positive Patients Attending at Debre Birhan Comprehensive Specialized Hospital, North Showa, Ethiopia

Table 3

Multidrug-resistant profile of enterococcal isolates at the Debre Birhan comprehensive hospital, May to August, 2021.

Resistance rate	Combination of antibiotics	No. (%) of isolates tested
R2	TE, DOXY,	2
R3	TE, DOXY, CIP	2
R4	TE, E, DOXY, VAN	2
R5	TE, E, DOXY, CIP, CAF	3
R6	E, CIP, CAF, AMP, P, AMC	3
R7	TE, E, CIP, CAF, AMP, P, AMC	4
R8	TE, E, DOXY, CIP, CAF, AMP, P, AMC	4
R8	TE, E, DOXY, CAF, AMP, P, AMC, VAN	3
R9	TE, E, DOXY, CIP, CAF, AMP, P, AMC, VAN	7
Total MDR ()		28

E = erythromycin; TE = tetracycline; AMP = ampicillin; P = penicillin; AMC = amoxicillin/clavulanic acid; CAF = chloramphenicol; CIP = ciprofloxacin; DOXY = doxycycline; VAN = vancomycin; R = resistance; R2-R9 = class of antibiotics resistance from 2 to 9, respectively; MDR = organisms resistant to ≥3 antibiotics.